Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
University of ColoradoFellowship, Infectious Disease, 1990 - 1995
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1985 - 1988
University of Texas Southwestern Medical SchoolClass of 1985
Certifications & Licensure
CO State Medical License 1988 - 2025
TX State Medical License 1986 - 1993- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings Start of enrollment: 2005 May 01
- A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe Start of enrollment: 2007 Jun 01
- Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsCardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients.Vincent Aketch Nyangwara, Tinashe Mazhindu, Zedias Chikwambi, Collen Masimirembwa, Thomas B Campbell
British Journal of Clinical Pharmacology. 2024-08-01 - 1 citationsMonocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.Sivaporn Gatechompol, Stephen J Kerr, Sandra W Cardoso, Wadzanai Samaneka, Srikanth Tripathy
AIDS. 2024-01-01 - 4 citationsPredictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in...Marta Epeldegui, Di Chang, Jeannette Lee, Larry I Magpantay, Margaret Borok
Journal of Acquired Immune Deficiency Syndromes. 2023-10-01
Press Mentions
Here’s How the COVID-19 Public Health Emergency Ending Will Impact ColoradansMay 11th, 2023- New COVID Variant XBB: Symptoms Doctors Are Seeing Right NowJanuary 6th, 2023
- CDC Study Backs Bivalent Booster Effectiveness. So Why Is Uptake so Low?December 12th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
